Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Mailman

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 2006
Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathwaysJonathan D Urban, Gabriel A Vargas, Mark von Zastrow, et al.
Eneuro|April 29, 2026
Effect of Functionally Selective Dopamine D<sub>1</sub> Receptor Agonists on Complex Cognitive Processes in a Rodent Touchscreen Operant Chamber TaskAva P Bassett, Luke Bransom, Richard B Mailman, et al.
Discover Pharmaceutical Sciences|July 3, 2026
Concomitant activation of D<sub>1</sub> dopamine and α<sub>2A</sub> adrenergic receptors improves cognition better than methylphenidate in two rodent behavioral testsLuke Bransom, Ava P Bassett, Mi Zhou, et al.
The International Journal of Biochemistry & Cell Biology|June 10, 2022
Dopamine D<sub>1</sub> receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior, and neurophysiologyYang Yang, Mechelle M Lewis, Xuemei Huang, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Quantifying network behavior in the rat prefrontal cortex: a reproducibility crisisCongzhou M Sha, Jian Wang, Richard B Mailman, et al.
Biological Psychiatry|March 7, 2016
Novel Dopamine Therapeutics for Cognitive Deficits in SchizophreniaAmy F T Arnsten, Ragy R Girgis, David L Gray, et al.
Journal of Biochemical and Molecular Toxicology|March 7, 2014
The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effectsByron C Jones, Xuemei Huang, Richard B Mailman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 3, 2008
Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging StudyXuemei Huang, Robert D Abbott, Helen Petrovitch, et al.
Frontiers in Computational Neuroscience|September 13, 2024
Quantifying network behavior in the rat prefrontal cortexCongzhou M Sha, Jian Wang, Richard B Mailman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2017
Projection of the prevalence of Parkinson's disease in the coming decades: RevisitedAlexander Rossi, Kristin Berger, Honglei Chen, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 2006
Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathwaysJonathan D Urban, Gabriel A Vargas, Mark von Zastrow, et al.
Eneuro|April 29, 2026
Effect of Functionally Selective Dopamine D<sub>1</sub> Receptor Agonists on Complex Cognitive Processes in a Rodent Touchscreen Operant Chamber TaskAva P Bassett, Luke Bransom, Richard B Mailman, et al.
Discover Pharmaceutical Sciences|July 3, 2026
Concomitant activation of D<sub>1</sub> dopamine and α<sub>2A</sub> adrenergic receptors improves cognition better than methylphenidate in two rodent behavioral testsLuke Bransom, Ava P Bassett, Mi Zhou, et al.
The International Journal of Biochemistry & Cell Biology|June 10, 2022
Dopamine D<sub>1</sub> receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior, and neurophysiologyYang Yang, Mechelle M Lewis, Xuemei Huang, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Quantifying network behavior in the rat prefrontal cortex: a reproducibility crisisCongzhou M Sha, Jian Wang, Richard B Mailman, et al.
Biological Psychiatry|March 7, 2016
Novel Dopamine Therapeutics for Cognitive Deficits in SchizophreniaAmy F T Arnsten, Ragy R Girgis, David L Gray, et al.
Journal of Biochemical and Molecular Toxicology|March 7, 2014
The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effectsByron C Jones, Xuemei Huang, Richard B Mailman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 3, 2008
Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging StudyXuemei Huang, Robert D Abbott, Helen Petrovitch, et al.
Frontiers in Computational Neuroscience|September 13, 2024
Quantifying network behavior in the rat prefrontal cortexCongzhou M Sha, Jian Wang, Richard B Mailman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2017
Projection of the prevalence of Parkinson's disease in the coming decades: RevisitedAlexander Rossi, Kristin Berger, Honglei Chen, et al.
Pageof 10